Douglas Crutchfield, C.R.N.A
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $946.93 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $573.89 | 30 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $102.93 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $97.14 | 7 | $0 (2022) |
| RedHill Biopharma Inc. | $74.38 | 4 | $0 (2022) |
| Madrigal Pharmaceuticals | $42.53 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $29.81 | 2 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $26.25 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $277.65 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($200.49) |
| 2023 | $347.11 | 19 | Takeda Pharmaceuticals U.S.A., Inc. ($249.00) |
| 2022 | $151.96 | 9 | Takeda Pharmaceuticals U.S.A., Inc. ($74.03) |
| 2021 | $170.21 | 11 | RedHill Biopharma Inc. ($52.45) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/03/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: LIVER DISEASE | ||||||
| 09/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.18 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/06/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/03/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/19/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/26/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/28/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/18/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/24/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/12/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 323 | 323 | $427,210 | $29,192 |
| 2022 | 4 | 345 | 346 | $481,850 | $32,259 |
| 2021 | 4 | 438 | 441 | $709,630 | $43,443 |
| 2020 | 4 | 417 | 418 | $715,540 | $43,499 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 106 | 106 | $149,800 | $9,248 | 6.2% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 97 | 97 | $74,550 | $8,829 | 11.8% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 70 | 70 | $100,030 | $5,615 | 5.6% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 50 | 50 | $102,830 | $5,501 | 5.3% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 97 | 98 | $79,520 | $9,127 | 11.5% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 103 | 103 | $157,150 | $8,859 | 5.6% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 69 | 69 | $134,540 | $7,472 | 5.6% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 76 | 76 | $110,640 | $6,801 | 6.1% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 152 | 152 | $249,030 | $13,412 | 5.4% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 109 | 110 | $117,880 | $10,931 | 9.3% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 82 | 82 | $185,360 | $9,753 | 5.3% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 95 | 97 | $157,360 | $9,347 | 5.9% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 137 | 137 | $245,070 | $12,892 | 5.3% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 112 | 113 | $129,150 | $11,806 | 9.1% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2020 | 85 | 85 | $200,550 | $10,492 | 5.2% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2020 | 83 | 83 | $140,770 | $8,310 | 5.9% |
About Douglas Crutchfield, C.R.N.A
Douglas Crutchfield, C.R.N.A is a Nurse Anesthetist, Certified Registered healthcare provider based in Eufaula, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003995176.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Douglas Crutchfield, C.R.N.A has received a total of $946.93 in payments from pharmaceutical and medical device companies, with $277.65 received in 2024. These payments were reported across 53 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($946.93).
As a Medicare-enrolled provider, Crutchfield has provided services to 1,523 Medicare beneficiaries, totaling 1,528 services with total Medicare billing of $148,394. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Nurse Anesthetist, Certified Registered
- Other Specialties Certified Registered
- Location Eufaula, OK
- Active Since 11/02/2006
- Last Updated 07/22/2010
- Taxonomy Code 367500000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003995176
Products in Payments
- ENTYVIO (Biological) $546.73
- DUPIXENT (Biological) $102.93
- TRULANCE (Drug) $82.79
- Talicia (Drug) $74.38
- RESMETIROM (Drug) $42.53
- OCALIVA (Drug) $26.25
- TREMFYA (Drug) $16.62
- XIFAXAN (Drug) $14.35
- GATTEX (Drug) $13.33
- STELARA (Biological) $13.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.